Exicure(us:XCUR)
18.67
+18.61%
Updated on 2024-12-22
Open:16.91
Close:18.67
High:19.50
Low:16.23
Pre Close:15.74
Volume:222813.00
Amount:4.06M
Turnover:8.55%
Shares:2.61M
MarketCap:48.65M
About Exicure Company
Exicure, Inc. develops therapeutics for immuno-oncology, genetic disorders and other indications based on its proprietary Spherical Nucleic Acid. Its product pipeline include Cavrotolimod (AST-008) and XCUR-FXN. The company was founded by Chad A. Mirkin and Colby Shad Thaxton in June 2011 and is headquartered in Skokie, IL.
Company Name: Exicure
Company Address: 2430 North Halsted Street
Employees: 6
Fiscar Year: 12-31
IPO Date: 2019-07-31
Website: http://www.exicuretx.com
CIK: 1698530
View all SEC Filings
About
Exicure, Inc. develops therapeutics for immuno-oncology, genetic disorders and other indications based on its proprietary Spherical Nucleic Acid. Its product pipeline include Cavrotolimod (AST-008) and XCUR-FXN. The company was founded by Chad A. Mirkin and Colby Shad Thaxton in June 2011 and is headquartered in Skokie, IL.
Address:2430 North Halsted Street
Website:http://www.exicuretx.com
Market Movers